Clinical Trials Directory

Trials / Unknown

UnknownNCT03009136

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis: Study Protocol for a Double-blind, Randomized, Parallel-group, Multi-center Trial

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
154 (estimated)
Sponsor
Kyung Hee University Hospital at Gangdong · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the short and long term efficacy and the safety of SCRT treatment for PAR

Conditions

Interventions

TypeNameDescription
DRUGSCRTcomposed of eight herbs: Glycyrrhiza uralensis Fischer 1g Zingiber officinale Roscoe 0.5g Cinnamomum cassia Blume 0.2g, Ephedra sinica Stapf 0.5g, Pinellia ternata Breitenbach 2.67g, Paeonia lactiflora PALL 1g, Asiasarum sieboldi F. Maekawa 0.5g, Schisandra chinensis 2.67g (per 9g of granules)
DRUGPlacebosis made of lactose, corn starch and caramel coloring, and has appearance, shape, weight, taste, and color similar to SCRT

Timeline

Start date
2016-12-31
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2017-01-04
Last updated
2017-03-14

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03009136. Inclusion in this directory is not an endorsement.

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis (NCT03009136) · Clinical Trials Directory